Related Experiment Video
Updated: Sep 27, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma
Yasushi Toh1, Manabu Yamamoto, Kazuya Endo
1Department of Gastroenterological Surgery, National Kyushu Cancer Center, Fukuoka 811-1395, Japan. ytoh@nk-cc.go.jp
Abstract:
The alterations of the chromatin structure by histone acetylases (HATs) and histone deacetylases (HDACs) are implicated in the regulation of gene transcription and also in the process of carcinogenesis. HDAC inhibitors have been shown to be potent inducers of growth arrest, differentiation and/or apoptotic cell death of transformed cells and, as a result, they are currently receiving considerable attention as antitumor agents. In this study, we examined the status of histone H4 acetylation and the level of HDAC1 expression in surgically resected specimens of human esophageal squamous cell carcinoma by immunohistochemistry. We herein demonstrate that histone H4 of esophageal carcinoma cells was significantly hyperacetylated in the early stage of cancer invasion and thereafter changed into a hypoacetylated state according to the degree of cancer progression. The cases in which HDAC1 was less expressed in esophageal carcinoma cells than in the normal mucosa significantly increased as the carcinoma invaded into the deeper layers of the esophageal wall. Furthermore, both the hyperacetylation of histone H4 and the high expression of HDAC1 were shown to topologically colocalize in the same tumor. These results suggested that a dynamic equilibrium between the HAT and HDAC activities is disrupted in esophageal carcinoma, thus implying that a certain interaction may exist between the hyperacetylation of histone H4 and the HDAC1 expression.
Insights
Histone acetylation changes and HDAC1 expression in esophageal cancer reveal disrupted epigenetic regulation. These findings suggest potential interactions between histone H4 hyperacetylation and HDAC1 levels in tumor progression.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Histone acetylases (HATs) and histone deacetylases (HDACs) regulate gene transcription and are involved in carcinogenesis.
- HDAC inhibitors are investigated as antitumor agents due to their ability to induce growth arrest, differentiation, and apoptosis in cancer cells.
Purpose of the Study:
- To investigate histone H4 acetylation status and HDAC1 expression in human esophageal squamous cell carcinoma.
- To explore the relationship between these epigenetic modifications and cancer progression.
Main Methods:
- Immunohistochemistry was used to examine surgically resected esophageal squamous cell carcinoma specimens.
- Analysis focused on histone H4 acetylation levels and HDAC1 expression.
Main Results:
- Histone H4 was hyperacetylated in early-stage esophageal cancer, becoming hypoacetylated as cancer progressed.
- Reduced HDAC1 expression correlated with deeper tumor invasion into the esophageal wall.
- Histone H4 hyperacetylation and high HDAC1 expression were found to colocalize within the same tumors.
Conclusions:
- A disruption in the balance between HAT and HDAC activities occurs in esophageal carcinoma.
- A potential interaction between histone H4 hyperacetylation and HDAC1 expression may play a role in esophageal cancer development and progression.
Related Concept Videos
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Variants at the Centromere
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
